Logo image of SHLT

SHL TELEMEDICINE LTD-ADR (SHLT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SHLT - US78423T2006 - ADR

2.05 USD
-0.03 (-1.44%)
Last: 4/2/2025, 8:00:02 PM
Fundamental Rating

2

SHLT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. The financial health of SHLT is average, but there are quite some concerns on its profitability. SHLT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SHLT had negative earnings in the past year.
In the past year SHLT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SHLT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: SHLT reported negative operating cash flow in multiple years.
SHLT Yearly Net Income VS EBIT VS OCF VS FCFSHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M -15M

1.2 Ratios

SHLT's Return On Assets of -8.60% is on the low side compared to the rest of the industry. SHLT is outperformed by 71.96% of its industry peers.
SHLT has a worse Return On Equity (-13.13%) than 62.62% of its industry peers.
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROIC N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
SHLT Yearly ROA, ROE, ROICSHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

SHLT's Gross Margin of 45.73% is fine compared to the rest of the industry. SHLT outperforms 73.83% of its industry peers.
SHLT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
SHLT Yearly Profit, Operating, Gross MarginsSHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

SHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SHLT has more shares outstanding than it did 1 year ago.
SHLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SHLT has been reduced compared to a year ago.
SHLT Yearly Shares OutstandingSHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
SHLT Yearly Total Debt VS Total AssetsSHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -0.08, we must say that SHLT is in the distress zone and has some risk of bankruptcy.
SHLT has a worse Altman-Z score (-0.08) than 76.64% of its industry peers.
SHLT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
SHLT has a better Debt to Equity ratio (0.20) than 69.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC7.08%
SHLT Yearly LT Debt VS Equity VS FCFSHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

SHLT has a Current Ratio of 2.17. This indicates that SHLT is financially healthy and has no problem in meeting its short term obligations.
SHLT has a Current ratio of 2.17. This is in the better half of the industry: SHLT outperforms 76.64% of its industry peers.
A Quick Ratio of 1.98 indicates that SHLT should not have too much problems paying its short term obligations.
The Quick ratio of SHLT (1.98) is better than 74.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.98
SHLT Yearly Current Assets VS Current LiabilitesSHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

SHLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -282.35%.
Looking at the last year, SHLT shows a decrease in Revenue. The Revenue has decreased by -2.04% in the last year.
The Revenue has been growing slightly by 3.16% on average over the past years.
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHLT Yearly Revenue VS EstimatesSHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SHLT Yearly EPS VS EstimatesSHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHLT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHLT Price Earnings VS Forward Price EarningsSHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHLT Per share dataSHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHL TELEMEDICINE LTD-ADR

NASDAQ:SHLT (4/2/2025, 8:00:02 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)04-24 2025-04-24
Inst Owners27.15%
Inst Owner Change0%
Ins Owners5.8%
Ins Owner ChangeN/A
Market Cap33.60M
Revenue(TTM)55.94M
Net Income(TTM)-8.84M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 23.16
P/B 0.5
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.09
OCFY4.32%
SpS3.41
BVpS4.11
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.73%
FCFM N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.04%
Cap/Sales 9.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.98
Altman-Z -0.08
F-Score5
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)76.24%
Cap/Depr(5y)63.01%
Cap/Sales(3y)9.3%
Cap/Sales(5y)7.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.12%
OCF growth 3YN/A
OCF growth 5YN/A

SHL TELEMEDICINE LTD-ADR / SHLT FAQ

Can you provide the ChartMill fundamental rating for SHL TELEMEDICINE LTD-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to SHLT.


Can you provide the valuation status for SHL TELEMEDICINE LTD-ADR?

ChartMill assigns a valuation rating of 0 / 10 to SHL TELEMEDICINE LTD-ADR (SHLT). This can be considered as Overvalued.


How profitable is SHL TELEMEDICINE LTD-ADR (SHLT) stock?

SHL TELEMEDICINE LTD-ADR (SHLT) has a profitability rating of 1 / 10.


What is the financial health of SHL TELEMEDICINE LTD-ADR (SHLT) stock?

The financial health rating of SHL TELEMEDICINE LTD-ADR (SHLT) is 4 / 10.


Is the dividend of SHL TELEMEDICINE LTD-ADR sustainable?

The dividend rating of SHL TELEMEDICINE LTD-ADR (SHLT) is 0 / 10 and the dividend payout ratio is 0%.